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ABSTRACT 
The developments of the polymerase chain reaction (PCR) and the short tandem 
repeat multiplex kits increased the ease and lowered the time and sample quantity 
required for deoxyribonucleic acid (DNA) typing compared to previous methods. 
However the amplification of low mass of DNA can lead to increased stochastic effects, 
such as allele drop-out (ADO) and heterozygous peak height (PH) imbalance, which 
make it difficult to determine the true donor profile. These stochastic effects are believed 
to be due to: 1) pre-PCR sampling from pipetting and sample transferal of dilute samples 
prior to amplification resulting in unbalanced heterozygous allele templates in the 
amplification reaction, and 2) the kinetics of the PCR process where, when few target 
templates are available, there is uneven amplification of heterozygous alleles during early 
PCR cycles. 
This study looks to examine the contribution of PCR chemistry and pre-PCR 
sampling errors on stochastic effects by utilizing a single-tube DNA extraction and direct 
amplification method. Cells were collected into tubes using the McCrone and Associates, 
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Inc. cell transfer method, which allowed for approximation of DNA mass without 
quantification. The forensicGEM® Saliva Kit was used to lyse the cells and inactivate 
nucleases without inhibiting downstream amplification. The samples were then directly 
amplified with the AmpFLSTR® Identifiler® Plus PCR Amplification Kit. These 
samples should only show the effects of PCR chemistry since pipetting and tube 
transferal steps prior to amplification were removed with the expectation that equal 
numbers of heterozygous alleles are present in the sample pre-amplification. 
Comparisons of PH imbalance were made to samples extracted with forensicGEM® but 
had one or more pipetting and tube transferal steps prior to amplification. These samples 
were either created through the dilution of stock DNA or from the cell transfer method 
where aliquots were then taken for amplification; thus these samples would exhibit the 
effects of both pre-PCR sampling and PCR chemistry errors and inefficiencies. The use 
of carrier ribonucleic acid (cRNA) was also added to cell transfer samples prior to the 
amplification of samples to see if it assisted with amplification and increased signal. 
Results show that the samples with only PCR chemistry generally have 
significantly higher mean peak height ratios (PHRs) than samples with both pre-PCR 
sampling and PCR chemistry except in cases where there were large numbers of ADOs. 
When compared to the diluted samples, the cell transfer samples had significantly higher 
mean PHR at 0.0625 ng and 0.125 ng, and higher mean PHR at 0.0375 ng when PHs 
from ADOs are included. Average peak heights (APHs) in the cell transfer samples were 
also significantly higher in these comparisons. When compared to aliquots taken from 
cell transfer samples, mean PHR was significantly higher at 0.0625 ng in cell transfer 
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samples with only PCR chemistry than cell transfer samples with both pre-PCR sampling 
and PCR chemistry; however APH for the samples with only PCR chemistry was also 
significantly higher in one experiment and not significantly different in another. In a third 
experiment, the difference in mean PHR was not significant while APH was significantly 
higher in the samples with pre-PCR sampling and PCR chemistry; however there were 
also a large numbers of ADOs. 
Our results also found quantification of dilute samples unreliable but cell counting 
through the cell transfer method is an appropriate alternative for DNA mass 
approximation. Also there were no significant changes in PHR or APH in the presence or 
absence of cRNA. 
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1. INTRODUCTION 
The use of deoxyribonucleic acid (DNA) typing has had a great impact in the field 
of forensic science. First introduced in 1985 by Jeffreys et al., DNA was found to have 
variable regions of tandem repeats that were highly polymorphic yet had low mutation 
rates, were somatically stable, and were inherited in a Mendelian fashion1,2. This allowed 
for individual identification that could be applied to forensic evidence samples, such as 
biological stains. The developments of the polymerase chain reaction (PCR) as well as 
the short tandem repeat (STR) multiplex kits increased the ease and lowered the time and 
sample quantity required for DNA typing compared to previously used methods3. 
Researchers have even been able to obtain complete STR profiles from minute amounts 
of DNA and even from single cells4; however the amplification of such a low mass of 
DNA can lead to stochastic effects commonly attributed to PCR chemistry. 
 
1.1 Polymerase Chain Reaction 
PCR has revolutionized molecular biology by allowing for sensitive and rapid 
creation of hundreds of millions of copies of specific DNA sequences. Copies are created 
in an exponential fashion by heating and cooling samples in specific thermal cycling 
patterns that consist of three steps3,5,6. In the denaturing step, the double-stranded DNA is 
heated to approximately 95 degrees Celsius (°C) to disrupt the hydrogen bonds and 
separate the strands into single-stranded template DNA. In the annealing step, the 
solution is cooled to approximately 60°C to allow short single-stranded DNA primers to 
bind to and flank the targeted regions of the template molecules. Finally in the elongation 
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step, the solution is heated to 72°C, which is the optimal temperature for Thermus 
aquaticus (Taq) polymerase to catalyze the extension of the primer sequencing and add 
nucleotides complementary to the template. At the end of a PCR cycle, the amount of 
targeted sequence has doubled and the newly synthesized DNA can be used as templates 
for the following cycle. The method requires knowledge of the DNA sequence to create 
two oligonucleotide primers that complement and flank the target region, 
deoxynucleotide triphosphates (dNTPs), which are required during extension, a DNA 
polymerase to facilitate replication, and other reagents such as buffer and ions to optimize 
replication. 
The oligonucleotide primers are used to identify the target DNA template 
sequence to be copied. After the DNA strands have been denatured, the single-stranded 
template will anneal with any complementary DNA sequences in solution, such as to 
other available template strands or to the primers. The forward and reverse primers are 
designed to flank the region of interest; one primer will bind to the sense strand at the 3’ 
end and the other primer to the 3’ end of the antisense strand3. Primers for different DNA 
targets  may also have attached fluorescent probes that are excited at a similar wavelength 
but give fluorescent emissions at different wavelengths, allowing for detection and 
multiplexing7. 
The primers used in forensic DNA analysis target repeating units of four or five 
base pairs called STRs, and the number of repeating units varies within a population. Due 
to the short length of STRs, the template that the STR primers bind to is more likely to 
withstand DNA degradation and small products are easier to amplify with PCR3. 
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Tetranucleotide STRs are the most commonly examined STRs in forensic analysis 
because they are more prevalent than pentranucleotide and hexanucleotide STRs, suffer 
from less stutter artifacts than dinucleotide and trinucleotide STRs, and give good 
resolution in size-based electrophoretic separation3. Also due to their small size, 
multiplexing with primer sets targeting different STR sequences is possible. Commercial 
kits contain primer sets that have similar annealing temperature, do not interact 
significantly with one another to form primer-dimers, are, for the most part, on different 
chromosomes or many megabases apart and thus separate independently during meiosis, 
and can be detected by different fluorescent probes3,8. By examining multiple STRs in a 
person, a DNA profile can be obtain that is individualizing. 
Another important component of the PCR process is the DNA polymerase. DNA 
polymerase attaches to the primer-template heteroduplex and facilitates the addition of 
dNTPs in their proper order complementing the base pair on the template DNA strand3. 
The first polymerase used for PCR was the Klenow fragment of Escherichia coli DNA 
polymerase I, which had to be freshly added during each PCR cycle since the enzyme 
was inactivated during the denaturation step6. This was time consuming and could 
introduce contamination due to repeated opening and closing of the tubes. The current 
DNA polymerase used is Taq, which is thermostable and can survive extended incubation 
at 95°C9. Although it is generally unaffected by the denaturing step, it can still be 
inactivated after many heating and cooling steps as well as create non-specific products 
below its optimal activation temperature3,9. 
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The dNTPs are also necessary for PCR. They are the building blocks used to 
create a complementary copy of the single-stranded template, eventually becoming 
double-stranded amplicons. At the beginning of PCR, a high concentration of dNTPs is 
freely available in solution. These dNPTs are eventually depleted as they are incorporated 
into the formation of the complementary copy, which may lower PCR efficiency with 
each cycle. 
In the early cycles of PCR where reagents are abundant, efficiency is believed to 
be 100 percent (%) where DNA copies increase exponentially with each cycle3. However 
as the reaction progresses through later cycles, there may be thermal damage to the 
template and polymerase, poor primer annealing due to competition between primers and 
templates to form double-stranded DNA, polymerase forming non-specific products, the 
depletion of primers and dNTPs, and the amount of primer-template heteroduplex 
outnumbering the amount of polymerase available; these factors all cause PCR efficiency 
to change cycle-to-cycle, generally decreasing with increasing cycle number10. As 
efficiency fall below 100%, a linear phase is reach and eventually replication plateaus 
when one or more of the components are exhausted3. PCR inhibitors found in a wide 
range of sources from foods to body fluids to soil to detergents can also lower PCR 
efficiency by interfering with cell lysis, which lowers the amount of available template, 
by causing nucleic acid degradation, and by inhibiting polymerase activity11. These 
inhibitors can lead to reduced signal or partial or complete amplification failure. Due to 
these difficulties, many STR kits recommend a minimum DNA input of 0.125 nanograms 
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(ng) although full profiles are possible from even a single cell4. However these low-
template DNA (LTDNA) profiles also see increased stochastic effects. 
 
1.2 Stochastic Effects 
Stochastic or random effects are believed to be due to the kinetics of the PCR 
process where, when a small amount of target template is available, the PCR primers may 
not consistently bind to the template DNA3. This results in an unequal amplification of 
two alleles at a heterozygous locus. It is well documented that stochastic effects are 
widely seen in LTDNA profiles, making interpretation difficult12,13. Four types of 
stochastic effects observed in LTDNA profiles are discussed below: drop-out, drop-in, 
increased stutter, and heterozygous peak height (PH) imbalance.  
Drop-out occurs when the profile does not exhibit an allele from a contributor. A 
loss of a single allele is called allele drop-out (ADO) and a loss of both alleles at a locus 
is called locus drop-out (LDO). At low DNA concentration, stochastic variation can 
cause one allele at a heterozygous locus to amplify preferentially, causing drop-out of the 
other allele12. Statistical modeling by Tvedebrink et al. showed that drop-out probability 
is not correlated with molecular weight but is locus dependent14. Drop-in, on the other 
hand, occurs when alleles are observed that cannot be attributed to any assumed 
contributor, which may result in a single-source profile being mistakenly interpreted as a 
mixture. A drop-in allele from a single DNA molecule is generally low and rare. Gill et 
al. found that, after increasing the number of PCR cycles in order to increase signal, there 
was a 0.3% occurrence of the same spurious allele appearing in two different samples15. 
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Drop-in should not be confused with gross laboratory contamination, which is easy to 
identify since the extra alleles should be seen across multiple samples. 
Stutter is a type of drop-in that is often described as a result of “strand slippage” 
during replication. This slippage creates additional alleles observed that are often either 
one full repeat unit shorter or longer than the true allele, although one repeat unit shorter 
is more common3. Using relative fluorescence unit (rfu) as a measurement of PH, 
stutter% is calculated as: 
% =
	
		
	
		
		100% 
Stutter% was found to vary by locus and increased with the number of core repeats16. 
Statistical modeling has shown that stutter increases linearly with PCR cycle number and 
that stutter is more apparent in lower DNA concentration amplification17. With increased 
PCR cycle, the stutter% may not only be greater than the general interpretation guideline 
of 15% of the true allele but may also exceed the height of the true allele itself12,15. The 
introduction of stutter, especially early in the PCR cycle can contribute to PH imbalance. 
Heterozygous PH imbalance is a large variation in height of the two alleles at a 
heterozygous locus. Peak height ratio (PHR) is calculated in two ways: 
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Using equation (1), PHRs are typically 0.60 or greater and under 0.60 is generally 
considered imbalance3,18. PHRs are found to be more variable at lower average peak 
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heights (APHs), and modeling suggests that the stutter ratio affects PHR especially when 
the alleles differ in size and that larger alleles amplify less efficiently because smaller 
alleles are easier to amplify in the allotted time and larger alleles are more susceptible to 
degradation18,19. Due to these stochastic effects, research in the past two decades has been 
dedicated to improving signal and DNA recovery in LTDNA samples. 
 
1.3 Low Template DNA Profile 
For LTDNA samples, there has been great focus in recovering the correct profile. 
The most popular technique of improving signal has been to increase the number of PCR 
cycles. Drop-outs observed at 28 PCR cycles are recovered when amplified with 34 PCR 
cycles; however the increase in sensitivity also leads to elevated stutter and drop-ins12,15. 
Increasing annealing time in each cycle to allow for ample extension time also improves 
PH but results in increased stochastic effects20. Another method suggests amplifying the 
sample in two steps in order to increase template copy number. First the template is 
divided into two samples and the forward and reverse primers are amplified separately so 
the template copies grow in a linear fashion. Then the samples are repooled and amplified 
again with both forward and reverse primers together. Although this process increased 
allele recovery, the alleles are not consistently amplified to equal heights, which may 
result in poor PHR21. One protocol for LTDNA samples combines many of these 
findings; it suggests increasing PCR cycle, reducing reaction volume, double annealing 
time, and adjusting capillary electrophoresis injection time and voltage22. 
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Another area of improvement is to increase DNA recovery. Methods have been 
developed to physically isolate individual cells to obtain pure cell populations. The use of 
laser microdissection (LMD) allows for visual detection and precise recovery of cells 
from which STR profiles have been successfully obtained23,24. Cell counting by 
techniques like LMD is also an accurate alternative to quantitation, which saves sample 
extract. Whole genome amplification (WGA) may also increase recovery of LTDNA 
samples amplified. This approach was tried with and without molecular crowding, which 
is the addition of large concentrations of macromolecules in vitro in order to recreate a 
crowded environment similar to cells in vivo25. Ballantyne et al. first amplified LTDNA 
samples with WGA in the presence of animal DNA as well as polyethylene glycol, a 
commonly used inert molecular crowding agent, and then performed STR amplification 
and they found an increased in the number of target alleles detected compared to samples 
without molecular crowding26. 
In order to interpret LTDNA profiles, the creation of a consensus profile has been 
commonly used. The sample is divided into three tubes and amplified and only alleles 
seen at least twice are considered true alleles27. The redundancy improves confidence and 
eliminates spurious alleles; however dividing an already low mass sample can increase 
stochastic effect in the profile, especially coupled with increased PCR cycles15,28. 
Although the focus in the past has been to improve profile recovery, it is also worthwhile 
to understand the cause of stochastic effects. 
It is believed that stochastic effects are due to the randomness in PCR chemistry 
where one heterozygous allele is preferentially amplified over the other. In the early 
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stages of PCR, there is an excess of reagent. If both heterozygous alleles are present in 
equivalent concentrations at the beginning of PCR, the PCR components should 
theoretically be able to amplify both alleles equally. However, as evident by Grisedale 
and van Daal’s method to increase template copy number, they were able to recover 
dropped alleles but the alleles were not amplified to equal heights21. This suggests that 
PH imbalance may be a result of the uneven concentrations of alleles due to sampling 
error since, if an allele does not exist in the sample, it cannot be detected regardless of 
any attempts to increase signal. 
 
1.4 Pre-PCR Sampling Error 
Researchers have simulated the variability of DNA template at low template copy 
where their models show an increase in signal variability and a decrease in quantification 
accuracy with the decrease in DNA template, which can be a result of stochastic 
distribution of DNA molecules lost in sample preparation and extraction, of samples 
binding to plastic ware, or of some other pre-PCR processing29–31. Using accurately 
diluted samples, Timken et al. found PHRs for samples amplified by two STR kits and 
analyzed on two different capillary electrophoretic platforms are similar when normalized 
for template DNA amount32. This suggests heterozygous PH balance is dependent on 
DNA concentration and not PCR chemistry. Their simulations of PHRs generated with 
pre-PCR sampling and/or PCR chemistry show that, although PCR chemistry does have 
an effect on PHRs variability in the low template range, PHR is mainly affected by the 
result of pre-PCR sampling.  
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Many current extraction and purification methods require multiple tube transfers 
and washes. Although purified DNA is obtained from these procedures, DNA yield is 
reduced in the process31. In order to minimize sampling error and obtain accurate DNA 
amounts, one can perform extraction and amplification in a single-tube. Meredith et al. 
developed an one-tube extraction and amplification method using LMD in order to obtain 
known DNA mass, minimize loss of DNA, and reduce potential for contamination33. 
Their one-tube protocol results in higher DNA yield and APHs than the recommended 
method for the Lyse-N-Go™ PCR Reagent extraction kit (Pierce Chemical Co., 
Rockford, IL), and they are able to obtain full STR profiles from as few as 15 epithelial 
cells and consistently obtain full profiles from 50 epithelial cells. Although not used by 
Meredith et al. an extraction method from ZyGEM Corporation Ltd. (Hamilton, New 
Zealand) uses proprietary proteinase from a thermophilic Bacillus species EA1 that does 
not require multiple steps of tube transfer and washes34. The proteinase is added into a 
tube containing biological samples and the tube is heated to 75°C in order to lyse the 
cells and inactivate nucleases. The nucleases are then digested by the proteinase before 
they can degrade the DNA and the proteinase is then inactivated at 94°C to prevent it 
from inhibiting Taq during PCR. The DNA in this extract can then be directly amplified 
using commercial STR kits.  
After minimizing sampling variability, one can determine if there is a decrease in 
stochastic effect. Kaeser developed a single-tube extraction and direct amplification 
protocol in order to determine the causes of stochastic effects35. Known number of cells 
are collected and extracted with forensicGEM® Saliva kit (ZyGEM Corporation Ltd., 
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Hamilton, New Zealand), which utilizes the EA1 proteinase, and directly amplified with 
Identifiler® PCR Amplification Kit (ID; Applied Biosystems®, Grand Island, New 
York) and Identifiler® Plus PCR Amplification Kit (ID+; Applied Biosystems®, Grand 
Island, New York) in a single-tube in order to minimize pre-PCR sampling, and the 
analysis of these profiles are then compared to profiles of DNA extractions diluted to 
comparable mass. Kaeser found that PHRs are significantly improved in the single-tube 
extracts at a total target mass of 0.0625 ng, which is approximately 10 cells, but there are 
no significant differences at a total target mass of 0.125 ng, which is equivalent to 20 
cells. More ADOs were seen in samples amplified with ID than those amplified with ID+, 
and ADOs were seen in both the cell transferred and diluted samples, suggesting that 
errors due to both pre-PCR sampling and PCR chemistry play a role in the development 
of stochastic effects in LTDNA. 
 
1.5 Objective 
This research is designed to replicate and extend Kaeser’s findings and examine 
the effects of pre-PCR sampling and PCR chemistry errors on PH imbalance in LTDNA 
samples. Protocols similar to those developed by Kaeser are used. The single-tube 
extraction created by forensicGEM® is used. Direct amplification is performed using the 
ID+ kit, which has been shown to recover more alleles and had fewer drop-outs than its 
predecessor ID35,36. In order to extract known numbers of cells to obtain a desired cell 
mass, the McCrone and Associates, Inc. (Westmont, Illinois) cell transfer method is used. 
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The experiments are designed with the goal of differentiating the effects of pre-
PCR sampling on PH imbalance from the effects of PCR chemistry on PH imbalance. 
This was accomplished using cell transfer collection then treatment with forensicGEM® 
compared to treatment with forensicGEM® followed by dilution to an equivalent target 
DNA mass, as illustrated in Figure 1A and Figure 1B. The cell transfer collection and 
treatment with forensicGEM® was also compared to cell transfer collection and 
treatment with forensicGEM® followed by aliquots taken of equivalent target DNA mass 
to be amplified (Figure 1B and Figure 1C). The samples extracted with forensicGEM® 
and directly amplified should demonstrate variation due to PCR chemistry only while 
those samples manipulated after extraction, either by diluting or aliquoting to other tubes, 
will show the effects of both PCR chemistry and pre-PCR sampling error. The use of 
carrier ribonucleic acid (cRNA) as a molecular crowding agent was also investigated to 
see if its presence could improve PH imbalance (Figure 1D). 
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Figure 1. Flowchart of the different experimental designs. A) Pre-PCR sampling was 
introduced through the dilution of stock DNA and aliquots taken for amplification. B) Pre-PCR 
sampling was removed by using a single-tube extraction and direct amplification method. C) Pre-
PCR sampling was introduced by taking aliquots from the single-tube extracts to be amplified. D) 
Molecular crowding through the use of cRNA was added to the single-tube extracts prior to 
amplification. 
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2. MATERIALS AND METHODS 
2.1 Samples and Extraction 
DNA samples were donated by two volunteers, donor C and A, with known ID+ 
profiles. Both donors have eleven heterozygous loci and four homozygous loci. Fresh 
liquid saliva samples were obtained from donor C and extracted using forensicGEM® 
Saliva kit and fresh buccal swabs were obtained from both donors and used to create 
smears on clean microscope slides. The smears were air-dried, and cell transfer and 
extraction were performed on the day of collection. 
 
2.1.1 forensicGEM® 
Two different protocols were used for forensicGEM® extractions: full volume 
and reduced volume extraction. 
The full volume extraction followed the method recommended by ZyGEM37. 
Twenty microliters (µL) of fresh liquid saliva, 10 µL of 10x Buffer BLUE, 69 µL of 
DNA free water, and 1 µL of forensicGEM® enzyme were added to a thin-walled PCR 
microtube, vortexed, and incubated in a GeneAmp® PCR System 9700 Thermal Cycler 
(Applied Biosystems®, Grand Island, New York). For the reagent blank, an additional 20 
µL of DNA free water was added in place of the 20 µL of liquid saliva. The tubes were 
first incubated at 75°C for 15 minutes, then 95°C for 5 minutes, and finally held at 4°C 
until removal from the thermal cycler. The tubes were vortexed at high speed for 1 
minute and then stored at -20°C until quantification. 
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A reduced volume protocol developed by Kaeser was used for the cell transfer 
extractions of 6, 10, and 20 epithelial cells35. 1 µL of 10x Buffer BLUE and 8 µL of 
DNA free water were mixed together in a thin-walled PCR microtube. Cells were then 
transferred to the mixture using the cell transfer protocol described below. After the 
desired numbers of cells were transferred, 1 µL of 1:10 diluted forensicGEM® enzyme 
was then added to the tube, giving a total volume of 10 µL. The tube was vortexed, 
incubated using the same thermal cycler program described above, vortexed at high speed 
for 1 minute following incubation, and stored at -20°C until quantification and/or 
amplification. For reagent blank controls, cells were not added to the tube, however 
adhesive from the tape used in cell transfer was included. 
A modified reduced volume protocol, henceforth known as the 100-cell 
extraction, was used for cell transfer extractions of 100 or more cells. Although the 
volumes of reagents were increased in order to obtain an expected DNA concentration of 
0.0625 ng/µL, the concentrations of reagents were maintained. For example, 100 cells 
were transferred to a mixture of 10 µL of 10x Buffer BLUE and 89 µL DNA free water 
before 1 µL of undiluted forensicGEM® was added, giving a total volume of 100 µL; 
each components is ten times the original reduced volume protocol. Incubation, 
vortexing, and storage of these extractions remained the same. 
 
2.1.2 Cell Transfer 
The cell transfer protocol was developed by Kaeser35 and adapted from the 
general guidelines found in a handbook provided by McCrone Associates, Inc.38 during a 
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workshop at the 63rd Annual Scientific Meeting of The American Academy of Forensic 
Sciences in 2011. In order to create a tungsten needle, a tungsten wire was cut to an 
approximately length of 1¼ inch. The piece was heated over a Bunsen burner until one 
end glowed red hot and then the heated tip was quickly inserted into and pulled out of a 
sodium nitrite stick to sharpen the wire. Once sharpened, the needle was placed into a 
beaker containing DNA free water to dissolve any sodium tungstate residue. The needle 
was removed from the beaker, air-dried, and stored until use. 
Buccal swab smears were observed under a Nikon Eclipse E200 microscope 
(Micro Video Instruments Inc., Avon, Massachusetts) at 10x magnification. When an 
epithelial cell was identified, it was viewed under 40x magnification to confirm it was a 
single, nucleated cell and magnification was returned to 10x. The tip of the tungsten 
needle was moistened with DNA free water and a small portion of adhesive from 
Scotch™ Brand Mask Plus II Water Soluble Wave Solder Tape (3M, St. Paul, 
Minnesota) was scraped onto the needle. The needle with adhesive was then scratched 
along the cell to dislodge the cell from the slide and to collect the cell onto the adhesive. 
The needle and adhesive could be used again to pick up additional cells until the adhesive 
began losing its tackiness. To add cells to the extraction microtubes, the adhesive end of 
the needle containing cells was dipped in PCR microtubes containing the Buffer BLUE 
and DNA free water solution, which dissolved the adhesive and released the cells into the 
mixture. This process was repeated until the desired number of cells was added to the 
PCR microtube. 
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2.2 Quantification 
DNA extractions were quantified using the Quantifiler® Human Quantification 
kit (Applied Biosystems®, Grand Island, New York) following the method described in 
the Quantifiler® Human User Guide39 and run on the 7500 Real-Time PCR System 
(Applied Biosystems®, Grand Island, New York). A mixture of 10.5 µL of Quantifiler® 
Human Primer Mix, 12.5 µL of Quantifiler® PCR Reaction Mix, and either 2 µL of 
DNA sample, 2 µL of Quantifiler® Human DNA Standard to be used as a positive 
control, or 2 µL of Tris-EDTA (TE) buffer to be used as a negative control were added to 
a well of an optical plate or 8-well strip. The samples were incubated according to the 
User Guide39 and a single standard curve was used to calculated the concentrations40. 
Quantification of the full volume extracts were run in duplicate while the quantification 
of the dilutions of the full volume extract were run in triplicate. To confirm the 
concentration of the samples extracted with the cell transfer/reduced volume protocol, six 
tubes of cell transfer samples containing either 10 or 20 cells were extracted with the 
reduced volume protocol and quantified. 
 
2.3 Sample Preparation 
2.3.1 Sample Dilution 
The concentrations of cell transfer extracts were estimated with the expectation 
that one cell contains approximately 6.25 picogram (pg) of genomic DNA3. Therefore 6 
cells contain approximately 37.5 pg, 10 cells contain approximately 62.5 pg, and 20 cells 
contain approximately 12.5 pg of genomic DNA. In order to mimic sampling events due 
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to pre-PCR processing, the forensicGEM® full volume extraction of liquid saliva was 
quantified and then diluted with 10x Buffer BLUE to the concentration of 0.0125 ng/µL. 
The 0.0125 ng/µL dilution was then further diluted to 0.00375 ng/µL and to 0.00625 
ng/µL and 10 µL were taken of the diluted samples for a total target mass of 0.0375 ng, 
0.0625 ng, and 0.125 ng. 
The cell transfer samples were not diluted since they were created to have specific 
target mass. For the reduce volume extracts, 6, 10, and 20 cells were collected to give the 
total target mass of 0.0375 ng, 0.0625 ng, and 0.125 ng in 10 µL of reagent, respectively. 
The 100-cell extracts were created to have the concentration of 0.00625 ng/µL, thus 10 
µL aliquots from the 100-cell extracts would have the total target mass of 0.0625 ng. 
 
2.3.2 Molecular Crowding 
The effect of molecular crowding was examined using cRNA provided with the 
QIAamp® DNA Investigator Kit (Qiagen, Venlo, Netherlands). The cRNA was 
dissolved in Buffer ATE, which is also provided by the QIAamp® kit, in order to obtain 
a concentration of 1 microgram (µg)/µL. Cell transfer samples were created with the 
reduced volume protocol to the total DNA mass of 0.0625 ng and 1 µL of cRNA was 
added to these samples, for the total volume of 11 µL. 
 
2.4 Amplification 
Samples were amplified using ID+ on a GeneAmp® PCR System 9700 following 
the procedure outlined in the User Guide41. 10 µL of ID+ Master Mix and 5 µL of ID+ 
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Primer Set were added into wells containing either 10 µL of DNA sample, 10 µL of 
9947A control DNA provided by the kit as the positive control, or 10 µL TE buffer used 
as a negative control. The samples were incubated in the thermal cycler at 95°C for 11 
minutes, then 28 cycles of 94°C for 20 seconds and 59°C for 3 minutes, and finally 60°C 
for 10 minutes before they are held at 4°C until removal from the thermal cycler. All 
samples were then stored at -20°C until capillary electrophoresis separation. 
 
2.5 Separation 
STR product separation was performed on a 3130 Genetic Analyzer (Applied 
Biosystem®, Grand Island, NY) according to the ID+ User Guide41. Each sample 
contained 0.3 µL GeneScan™ 600 LIZ® dye Size Standard, 8.7 µL Hi-Di™ Formamide, 
and 1 µL of either DNA sample or ID+ allelic ladder. POP-4™ was utilized as the 
polymer and samples were injected at 3 kilovolts for 10 seconds. 
 
2.6 Analysis 
Profiles were generated using GeneMapper® ID-X software, version 1.4, with the 
Local Southern Method. Two profiles were exported, one generated with a 
GeneMapper® peak amplitude setting, or an analytical threshold (AT), of 30 rfu and the 
other with an AT of 10 rfu. Only the peaks of known contributor alleles were included; 
all other software-labeled peaks were deleted. For profiles exported with an AT of 10 rfu, 
the electropherograms were manually examined for any known peaks that fell below 10 
rfu and their height was recorded for analysis; however if no peak was detected, an rfu of 
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1 was assigned. If there was complete LDO where the peak of a homozygous allele or 
both peaks of the heterozygous alleles at a locus were not observed, that locus was 
excluded from analyses. 
The profiles were exported to Microsoft Excel 2010 and JMP 11, version 11.2.1 
for statistical analysis. Averages and standard deviations (StDevs) for quantification were 
calculated using Excel AVERAGE and STDEV functions. PHR was calculated as the rfu 
of the shorter heterozygous allele over the rfu of the taller sister allele. APH was 
calculated as the addition of the rfu values for the two heterozygous alleles divided by 
two, or the rfu value of the homozygous allele divided by two. 
Oneway analysis of variance (ANOVA) and the Tukey-Kramer test were 
performed in JMP. JMP generates graphs where the black dots represent individual data 
points while the gray horizontal line running through the graphs is the grand mean. In the 
ANOVA graphs, the green diamond represents the 95% confidence interval with the 
mean as the middle green horizontal line. The green horizontal lines above and below the 
mean are the overlap marks where, if means of data sets of equivalent sizes fall between 
these two marks, the means are not significantly different. Tukey-Kramer test results are 
represented as circles where the further apart the circles are the more significantly 
different the means are. Numbers in data tables were rounded to three significant figures 
except in the quantification result tables where they were rounded to two significant 
figures or four decimal places, whichever had fewer decimal places.  
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3. RESULTS AND DISCUSSION 
DNA samples of various LTDNA mass were created with and without pre-PCR 
sampling in order to differentiate the stochastic effects of pre-PCR sampling and the 
stochastic effects of the PCR chemistry on measured PHR. Samples where pre-PCR 
sampling was avoided were created with the cell transfer/reduced volume protocol 
(Figure 1B) while samples with pre-PCR sampling were created either by dilution of a 
full volume extraction (Figure 1A) or by the 100-cell extraction method (Figure 1C). The 
use of cRNA as a molecular crowding agent was also used to observe whether it 
improved PH imbalance in LTDNA samples (Figure 1D). After ID+ amplification, 
samples were first analyzed with an AT of 30 rfu; this analysis excluded ADOs that had 
PHs of less than 30 rfu. Analysis was repeated with an AT of 10 rfu to include detectable 
PHs of all known contributor alleles; any alleles that were not detected were assigned a 
PH of 1 rfu unless there was LDO, which was excluded from analysis. 
 
3.1 Verification of DNA Concentrations 
In order to set up PCR reactions with approximately equal number of template 
copies, it is important to have an accurate measurement of DNA concentrations and to 
verify that the cell transfer sample extracts fall within the expected mass for the numbers 
of cells transferred. Liquid saliva from donor C was extracted using the forensicGEM® 
full volume extraction method and quantified with Quantifiler® Human Quantification 
kit in duplicate. The concentration of the saliva extract was 0.625 ng/µL with a StDev of 
0.0095. The extract was diluted to 0.0125 ng/µL and the 0.0125 ng/µL dilution was then 
22 
used to create samples with concentrations of 0.00625 ng/µL and 0.00375 ng/µL. These 
concentrations were chosen to mimic cell transfer extracts of approximately 20, 10, and 6 
cells, respectively, in a 10 µL volume. The diluted samples of 0.00625 ng/µL and 0.0125 
ng/µL were quantified in triplicate to confirm their concentrations. The 0.00375 ng/µL 
dilution was not quantified because it was at the lower end of the kit’s range of 
detection39. Triplicates of 10 and 20 cells from donor C were also transferred into 10 µL, 
extracted using the forensicGEM® reduced volume extraction protocol, and quantified to 
verify the numbers of cells transferred. 
Results for the stock dilutions showed a mean concentration of 0.021 ng/µL with 
a StDev of 0.0092 for the “0.0125 ng/µL” sample, which is greater than expected (Table 
1). The variation ranged from 0.013 ng/µL to 0.031 ng/µL, which is approximately 20 to 
49 cells. The “0.00625 ng/µL” sample had a mean concentration of 0.0034 ng/µL with a 
StDev of 0.0031 and the variation ranged from 0.0008 ng/µL to 0.0068 ng/µL, which is 
approximately 1 to 10 cells. Although the variation encompasses the target mass, it may 
be lower than desired. 
 
Table 1. Quantification results of the stock diluted samples. Liquid saliva from donor C was 
extracted with the forensicGEM® full volume extraction protocol, diluted to the desired 
concentrations of 0.0125 ng/µL and 0.00625 ng/µL based on the original DNA concentration, and 
quantified in triplicate. 
Method Target (ng/µL) Concentrations (ng/µL) Mean (ng/µL) StDev 
Stock Dilution 0.0125 0.013 0.017 0.031 0.021 0.0092 
0.00625 0.0025 0.0068 0.0008 0.0034 0.0031 
 
The cell transfer/reduced volume samples showed less variation than the full 
volume diluted samples. The 20-cell extracts had a mean concentration of 0.011 ng/µL 
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with a StDev of 0.0045 and the 10-cell extracts had a mean concentration of 0.0051 
ng/µL with a StDev of 0.0014 (Table 2). The variation in the 20-cell extracts ranged from 
0.0068 ng/µL to 0.016 ng/µL, which is approximately 10 to 25 cells, while the variation 
in the 10-cell extracts ranged from 0.0040 ng/µL to 0.0067 ng/µL, which is 
approximately 6 to 10 cells. 
 
Table 2. Quantification results of cell transfer extracts. Buccal epithelial cells from donor C 
were collected into three samples containing 20 cells and three samples containing 10 cells. The 
samples were extracted with the forensicGEM® reduced volume protocol and quantified with 
Quantifiler® Human Quantification kit. 
Approximate Number 
of Cells Transferred 
Target 
(ng/µL) 
Concentrations (ng/ul) Mean 
(ng/µL) 
StDev 
20 0.0125 0.011 0.0068 0.016 0.011 0.0045 
10 0.00625 0.0040 0.0046 0.0067 0.0051 0.0014 
 
 
3.2 Comparison of Pre-PCR Sampling Error and PCR Chemistry Error via Cell 
Transfer and Stock Dilution 
DNA from donor C was extracted both with the cell transfer/reduced volume and 
full volume protocols, as illustrated in Figure 2. The cell transfer samples were created to 
have the target mass of 0.0375 ng, 0.0625 ng, and 0.125 ng of DNA through the 
collection of 6, 10, and 20 cells in 10 µL volume, respectively, extraction using the 
reduced volume protocol, and finally direct amplification. The full volume extraction was 
diluted to the approximate concentration of 0.00375 ng/µL, 0.00625 ng/µL, and 0.0125 
ng/µL and 10 µL aliquots of the stock dilutions were then amplified at the target mass of 
0.0375 ng, 0.0625 ng, and 0.125 ng, respectively. All samples were run in replicates of 
10. Due to sample transferals from dilution as well as aliquots taken for amplification, the 
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stock diluted samples are susceptible to pre-PCR sampling variation, while the cell 
transfer samples utilized a single-tube extraction protocol and were directly amplified, 
thus removing pre-PCR sampling. 
 
Figure 2. Flowchart of the creation of the cell transfer and stock dilution samples. Ten 
replicate of each target masses were made using (A) the cell transfer and reduced volume 
extraction protocol and (B) the full volume extraction protocol followed by stock dilution. 
 
 
3.2.1 Comparison of DNA Mass 
Regardless of the extraction method used, the samples were created to have the 
target masses of approximately 0.0375 ng, 0.0625 ng, and 0.125 ng when amplified. The 
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PHR at each locus was calculated and plotted together by target mass. Mean PHRs were 
statistically different at the different target masses examined (Figure 3; Table 3 and Table 
4). When ADOs with PHs under 30 rfu were excluded, the mean PHR of the 0.125 ng 
samples were statistically different from 0.0625 ng (p-value=0.0005) and 0.0375 ng (p-
value<0.0001); however the two lower masses were not statistically different from each 
other (p-value=0.286). When all loci were included in analysis, the mean PHR of all three 
masses were statistically different from one another. Mean PHR also decreased as target 
masses decreased and the number of ADOs increased as target masses decreased, 
corroborating data reported by others that there is greater PH imbalance in samples with 
low DNA mass12,13,29,31. 
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Figure 3. Mean comparison of combined PHRs for the cell transfer and stock diluted 
samples created from donor C. DNA from donor C was extracted to the target masses of 
approximately 0.0375 ng, 0.0625 ng, and 0.125 ng using either cell transfer or stock dilution. The 
PHRs at each locus, represented by the black dots, were combined for both methods at each target 
mass and then analyzed with ANOVA and Tukey-Kramer analysis with an alpha level of 0.05. 
An AT of 30 rfu was used in (A) while the AT of 10 rfu analysis was used in (B).  
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Table 3. ANOVA analysis of combined PHRs for the cell transfer and stock diluted samples 
created from donor C. 
AT Used? Target 
Mass (ng) 
Number 
of Loci 
Mean 
PHR 
Standard 
Error 
Lower 
95% 
Upper 
95% 
p-value 
30 rfu 0.0375 162 0.755 0.0116 0.732 0.778 <0.0001 
0.0625 212 0.778 0.0101 0.758 0.798 
0.125 220 0.832 0.0100 0.813 0.852 
10 rfu 0.0375 220 0.674 0.0130 0.648 0.699 <0.0001 
0.0625 220 0.760 0.0130 0.734 0.785 
0.125 220 0.832 0.0130 0.807 0.858 
 
Table 4. Tukey-Kramer analysis of combined PHRs for the cell transfer and stock diluted 
samples created from donor C. 
AT Used? Target Mass (ng) 
Comparisons 
Difference Standard Error 
Difference 
p-value 
30 rfu 0.0375 0.0625 0.0233 0.0154 0.286 
0.0375 0.125 0.0774 0.0153 <0.0001 
0.0625 0.125 0.0541 0.0142 0.0005 
10 rfu 0.0375 0.0625 0.0859 0.0183 <0.0001 
0.0375 0.125 0.159 0.0183 <0.0001 
0.0625 0.125 0.0727 0.0183 0.0002 
 
 
3.2.2 Comparison of Extraction Methods 
At all target masses examined, mean PHR for the cell transfer samples were 
higher than the stock diluted samples (Figure 4; Table 5). Using an AT of 30rfu, the cell 
transfer and stock diluted samples were not statistically different at 0.0375 ng (p-
value=0.1667), however they were significantly different at the other two masses 
examined at both AT of 30 and 10 rfu (p-value<0.0001). More ADOs were also observed 
in the stock volume diluted samples than the cell transfer samples at 0.0375 ng and 
0.0625 ng. There were no ADOs at 0.125 ng for either method. 
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Figure 4. Mean comparison of PHRs for samples created from donor C separated by DNA 
mass and extraction method. DNA from donor C was extracted to the target masses of 
approximately 0.0375 ng, 0.0625 ng, and 0.125 ng using either cell transfer or stock dilution. The 
PHRs at each locus, represented by the black dots, were analyzed with ANOVA. Target mass of 
0.125 ng did not have any ADOs when analyzed with an AT of 30 rfu. 
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Table 5. ANOVA analysis of PHRs for samples created from donor C separated by target 
mass and extraction method. The three target masses analyzed were approximately (A) 0.0375 
ng, (B) 0.0625 ng, and (C) 0.125 ng. 
A) AT Used? Extraction 
Method 
Number 
of Loci 
Mean 
PHR 
Standard 
Error 
Lower 
95% 
Upper 
95% 
p-value 
30 rfu Cell 
Transfer 
106 0.768 0.157 0.737 0.799 0.1667 
Stock 
Dilution 
56 0.731 0.0216 0.688 0.773 
10 rfu Cell 
Transfer 
110 0.760 0.0221 0.717 0.804 <0.0001 
Stock 
Dilution 
110 0.587 0.0221 0.544 0.631 
  
B) AT Used? Extraction 
Method 
Number 
of Loci 
Mean 
PHR 
Standard 
Error 
Lower 
95% 
Upper 
95% 
p-value 
30 rfu Cell 
Transfer 
110 0.826 0.0148 0.797 0.856 <0.0001 
Stock 
Dilution 
102 0.726 0.0155 0.696 0.756 
10 rfu Cell 
Transfer 
110 0.826 0.0169 0.793 0.860 <0.0001 
Stock 
Dilution 
110 0.693 0.0169 0.659 0.726 
  
C) Note Extraction 
Method 
Number 
of Loci 
Mean 
PHR 
Standard 
Error 
Lower 
95% 
Upper 
95% 
p-value 
No ADOs 
observed 
at 30 rfu 
Cell 
Transfer 
110 0.867 0.0109 0.846 0.889 <0.0001 
Stock 
Dilution 
110 0.797 0.0109 0.776 0.819 
 
 
Quantification results had suggested that the concentration of the stock diluted 
samples may not be as expected where the “0.125 ng” stock diluted samples may be the 
same or greater than intended while the “0.0625” ng stock diluted samples may be the 
same or lower than expected (Table 1). APH analysis, however, shows that the stock 
diluted samples had significantly lower APH than the cell transfer samples except when 
analyzed with an AT of 30 rfu at 0.0375 ng (Figure 5; Table 6). This suggests the mass of  
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Figure 5. Mean comparison of APHs for samples created from donor C separated by target 
mass and extraction method. DNA from donor C was extracted to the target masses of 
approximately 0.0375 ng, 0.0625 ng, and 0.125 ng using either cell transfer or stock dilution. The 
APHs at each locus, represented by the black dots, were analyzed with ANOVA. The y-axis scale 
changes with each target mass. Target mass of 0.125 ng did not have any ADOs when analyzed 
with an AT of 30 rfu. 
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Table 6. ANOVA analysis of APHs for samples created from donor C separated by target 
mass and extraction method. The three target masses analyzed were approximately (A) 0.0375 
ng, (B) 0.0625 ng, and (C) 0.125 ng. 
A) AT Used? Extraction 
Method 
Number 
of Loci 
Mean 
APH 
(rfu) 
Standard 
Error 
(rfu) 
Lower 
95% 
(rfu) 
Upper 
95% 
(rfu) 
p-value 
30 rfu Cell 
Transfer 
146 79.0 2.80 73.5 84.5 0.0231 
Stock 
Dilution 
95 68.8 3.47 62.0 75.7 
10 rfu Cell 
Transfer 
150 78.0 2.78 72.5 83.4 <0.0001 
Stock 
Dilution 
150 53.6 2.78 48.1 59.1 
  
B) AT Used? Extraction 
Method 
Number 
of Loci 
Mean 
APH 
(rfu) 
Standard 
Error 
(rfu) 
Lower 
95% 
(rfu) 
Upper 
95% 
(rfu) 
p-value 
30 rfu Cell 
Transfer 
150 146 3.90 138 153 <0.0001 
Stock 
Dilution 
142 113 3.80 105 120 
10 rfu Cell 
Transfer 
150 146 3.75 138 153 <0.0001 
Stock 
Dilution 
150 109 3.75 102 117 
  
C) Note Extraction 
Method 
Number 
of Loci 
Mean 
APH 
(rfu) 
Standard 
Error 
(rfu) 
Lower 
95% 
(rfu) 
Upper 
95% 
(rfu) 
p-value 
No ADOs 
observed 
at 30 rfu 
Cell 
Transfer 
150 286 5.92 274 297 <0.0001 
Stock 
Dilution 
150 190 5.92 178 201 
 
 
the diluted samples may be lower than expected. Although the difference in PHR may be 
a result of pre-PCR sampling errors, we are unable to guarantee it is not the result of the 
DNA mass differences since lower DNA mass also show greater PH imbalance. 
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3.3 Comparison of Pre-PCR Sampling Error and PCR Chemistry Error via Cell 
Transfer 
Since we were unable to accurately dilute DNA samples to the desired 
concentrations with confidence, samples were created to include pre-PCR sampling 
errors using only the cell transfer/reduce volume protocol with one instance to sampling, 
as illustrated in Figure 6. Following the 100-cell extraction protocol, one hundred or 
more cells were collected and extracted in one large parent extract such that the 
concentration would be approximately 10 cells’ worth of DNA per 10 µL. Ten aliquots of 
10 µL with the target mass of approximately 0.0625 ng were taken from this parent 
extract in order to introduce pre-PCR sampling variation. These samples were then 
compared to 10 replicate of 10-cell extracts with the target mass of 0.0625 ng that were 
created using a single-tube extraction protocol and directly amplified. Each sample of 10 
µL should contain approximately 10 cells’ worth of DNA; however sister chromosomes 
would have disassociated in solution so equal number of heterozygous allele template 
would not necessarily be expected to be present in each amplification tube. 
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Figure 6. Flowchart of the creation of the 10-cell and 100-cell extracts. The cell transfer and 
forensicGEM® reduced volume protocols were used to create (A) ten 10-cell extracts and (B) ten 
aliquots were taken from the 100-cell extracts. 
 
3.3.1 Comparison of DNA Mass 
The 10-cell extracts created using the cell transfer/reduced volume extraction 
protocol were performed in three different experiments. The first and second experiment 
used DNA extracted from donor C while the third experiment used DNA from donor A. 
Although the DNA samples were extracted, amplified, and separated on the same 
equipment, the experiments were performed months apart where some equipment had 
undergone maintenance. Also there were differences in the amplification kits used; the 
ID+ kit used for experiment 1 was a different kit with a different lot number than the kit 
used for experiment 2 and 3 while experiment 2 and 3 used the same ID+ kit. The 10-cell 
34 
extracts across the three experiments should have approximately the same amount of 
DNA mass; however their APHs were statistically different from one another (p-
value<0.0001; Figure 7; Table 7). The difference in APH may be a result of the 
differences in kit as well as differences in loci since donor A and C were heterozygous at 
difference loci. 
 
 
Figure 7. Mean comparison of APHs for samples created using the 10-cell extraction across 
three experiments. Ten buccal epithelial cells were collected and extracted to have the 
approximate target mass of 0.0625 ng in all three experiments. Experiment 1 and 2 used DNA 
extracted from donor C while experiment 3 used DNA extracted from donor A. The APHs were 
plotted by experiment number with (A) an AT of 30 rfu and (B) with the AT of 10 rfu analysis. 
 
Table 7. ANOVA analysis of APHs for samples created using the 10-cell extraction across 
three experiments. 
AT Used? Experiment 
Number 
Number 
of Loci 
Mean 
APH 
(rfu) 
Standard 
Error 
Lower 
95% 
Upper 
95% 
p-value 
30 rfu 1 150 184 3.31 177 191 <0.0001 
2 148 100 3.33 93.8 107 
3 109 56.8 3.88 49.2 64.5 
10 rfu 1 150 184 3.27 178 191 <0.0001 
2 150 99.3 3.27 92.8 106 
3 150 47.4 3.27 40.9 53.8 
 
 
On the other hand mean PHRs of the 10-cell extracts were not statistically 
different when an AT of 30 rfu was used across the three experiments (p-value=0.484), 
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but the mean PHR of experiment 3 was statistically different from the other two 
experiments when the AT of 10 rfu analysis was used (Figure 8; Table 8 and Table 9). 
Experiment 3 contained a larger number of ADOs compared to the other two 
experiments; with an AT of 30 rfu, there were forty-one loci not included in the PHR 
analysis for experiment 3 compared to no drop-out in experiment 1 and two loci not 
included in experiment 2. Although experiment 1 had a higher APH than experiment 2, 
their PHR was not statistically different. This suggests that although mean APH may be 
statistically different, it is DNA mass that affects PHR.  
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Figure 8. Mean comparison of PHRs for samples created using the 10-cell extraction across 
three experiments. Ten buccal epithelial cells were collected and extracted to have the 
approximate target mass of 0.0625 ng in all three experiments. Experiment 1 and 2 used DNA 
extracted from donor C while experiment 3 used DNA extracted from donor A. The PHRs were 
analyzed with ANOVA and Tukey-Kramer analysis with an alpha level of 0.05. The PHRs were 
plotted by experiment number with (A) an AT of 30 rfu and (B) with the AT of 10 rfu analysis. 
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Table 8. ANOVA analysis of PHRs for samples created using the 10-cell extraction across 
three experiments. 
AT Used? Experiment 
Number 
Number 
of Loci 
Mean 
PHR 
Standard 
Error 
Lower 
95% 
Upper 
95% 
p-value 
30 rfu 1 110 0.808 0.0128 0.783 0.834 0.484 
2 108 0.810 0.0130 0.785 0.836 
3 72 0.787 0.0159 0.756 0.819 
10 rfu 1 110 0.808 0.0158 0.777 0.839 0.0001 
2 110 0.799 0.0158 0.768 0.830 
3 110 0.720 0.0158 0.689 0.741 
 
Table 9. Tukey-Kramer analysis of PHRs for samples created using the 10-cell extraction 
across three experiments. 
AT Used? Experiment 
Comparisons 
Difference Standard Error 
Difference 
p-value 
30 rfu 1 2 0.00180 0.0182 0.995 
1 3 0.0211 0.0204 0.556 
2 3 0.0229 0.0205 0.503 
10 rfu 1 2 0.00969 0.0223 0.901 
1 3 0.0880 0.0223 0.0003 
2 3 0.0783 0.0223 0.0015 
 
3.3.2 Comparison of Cell Transfer with and without Sampling 
The 10-cell extracts in the three experiments described in the previous section 
were also compared to 100-cell extracts in each experiment. In the first experiment, mean 
PHR in the cell transfer samples without pre-PCR sampling was significantly higher than 
samples with pre-PCR sampling; however APH was also significantly higher in the cell 
transfer samples without pre-PCR sampling than those with pre-PCR sampling (Figure 9; 
Table 10 and Table 11). Due to human error fewer cells were collected in the 100-cell 
extract, resulting in each aliquot having approximately 9 cells’ instead of 10 cells’ worth 
of DNA; this may explain the difference in APH. A single ADO was observed in the cell 
38 
transfer samples with pre-PCR sampling when an AT of 30 rfu was used, but there were 
no statistical changes in mean PHR or APH when the ADO was included or excluded 
from the calculations. 
 
Figure 9. Mean comparison of PHRs and APHs for samples created from donor C using the 
10-cell and 100-cell extraction protocols with and without pre-PCR sampling. Buccal 
epithelial cells from donor C were extracted to the target mass of 0.0625 ng. PHR and APH were 
analyzed with ANOVA using an AT of 30 rfu. 
 
 
Table 10. ANOVA analysis of PHRs for samples created from donor C using the 10-cell and 
100-cell extraction protocols with and without pre-PCR sampling. 
AT Used? Pre-PCR 
Sampling? 
Number 
of Loci 
Mean PHR Standard 
Error 
Lower 
95% 
Upper 
95% 
p-value 
30 rfu No 110 0.808 0.0161 0.777 0.840 0.0001 
Yes 98 0.716 0.0171 0.683 0.750 
10 rfu No 110 0.808 0.0163 0.776 0.841 <0.0001 
Yes 99 0.712 0.0172 0.678 0.746 
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Table 11. ANOVA analysis of APHs for samples created from donor C using the 10-cell and 
100-cell extraction protocols with and without pre-PCR sampling. 
AT Used? Pre-PCR 
Sampling? 
Number 
of Loci 
Mean APH (rfu) Standard 
Error 
Lower 
95% 
Upper 
95% 
p-value 
30 rfu No 150 184 4.57 175 193 <0.0001 
Yes 134 149 4.84 140 159 
10 rfu No 150 184 4.60 175 193 <0.0001 
Yes 135 148 4.85 139 158 
 
In the second experiment, mean PHR was statistically significant where the cell 
transfer samples directly amplified had higher mean PHR than the cell transfer samples 
with pre-PCR sampling (p-value<0.0001; Figure 10; Table 12). APH, on the other hand, 
was not significantly different, implying that the samples had similar masses (Figure 10; 
Table 13). More ADOs were also observed in the cell transfer samples with pre-PCR 
sampling when an AT of 30 rfu was used; five loci were excluded in the cell transfer 
samples with pre-PCR sampling while two loci were excluded in the samples without 
pre-PCR sampling. There were no statistical changes in mean PHR and APH when these 
loci are included in calculations. These results suggest that PH imbalance is a result of 
pre-PCR sampling and not due to the difference in DNA mass. 
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Figure 10. Mean comparison of PHRs and APHs for samples created from donor C using 
the 10-cell and 100-cell extraction protocols with and without pre-PCR sampling. Buccal 
epithelial cells from donor C were extracted to the target mass of 0.0625 ng. PHR and APH were 
analyzed with ANOVA using an AT of 30 rfu. 
 
Table 12. ANOVA analysis of PHRs for samples created from donor C using the 10-cell and 
100-cell extraction protocols with and without pre-PCR sampling. 
AT Used? Pre-PCR 
Sampling? 
Number 
of Loci 
Mean 
PHR 
Standard 
Error 
Lower 
95% 
Upper 
95% 
p-value 
30 rfu No 108 0.810 0.0149 0.781 0.840 <0.0001 
Yes 105 0.714 0.0151 0.684 0.743 
10 rfu No 110 0.799 0.0164 0.766 0.831 <0.0001 
Yes 110 0.701 0.0164 0.668 0.733 
 
Table 13. ANOVA analysis of APHs for samples created from donor C using the 10-cell and 
100-cell extraction protocols with and without pre-PCR sampling. 
AT Used? Pre-PCR 
Sampling? 
Number 
of Loci 
Mean APH 
(rfu) 
Standard 
Error 
Lower 
95% 
Upper 
95% 
p-value 
30 rfu No 148 100 2.51 95.4 105 0.694 
Yes 145 102 2.53 96.7 107 
10 rfu No 150 99.2 2.59 94.1 104 0.874 
Yes 150 99.8 2.59 94.7 105 
 
In the experiment 3, DNA extracted from donor A was used. Although the mean 
PHR of the cell transfer samples created without pre-PCR sampling was higher than 
samples with pre-PCR sampling, the results were not significant (Figure 11; Table 14). 
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APH, on the other hand, was statistically significant where the samples with pre-PCR 
sampling had a higher mean APH than the samples without pre-PCR sampling (Figure 
11; Table 15). The difference in APH, and therefore DNA mass, may be the cause of the 
insignificant PHR difference. With an AT of 30 rfu, this experiment also suffered from a 
greater number of ADOs than the previous two experiments; there were forty-one loci 
excluded in the samples without pre-PCR sampling and twenty-seven loci excluded in the 
samples with pre-PCR sample with six being complete LDO. 
 
 
Figure 11. Mean comparison of PHRs and APHs for samples created from donor A using 
the 10-cell and 100-cell extraction protocols with and without pre-PCR sampling. Buccal 
epithelial cells from donor A were extracted to the target mass of 0.0625 ng. PHR and APH were 
analyzed with ANOVA. 
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Table 14. ANOVA analysis of PHRs for samples created from donor A using the 10-cell and 
100-cell extraction protocols with and without pre-PCR sampling. 
AT Used? Pre-PCR 
Sampling? 
Number 
of Loci 
Mean 
PHR 
Standard 
Error 
Lower 
95% 
Upper 
95% 
p-value 
30 rfu No 72 0.787 0.0176 0.752 0.822 0.186 
Yes 87 0.756 0.0160 0.724 0.787 
10 rfu No 110 0.720 0.0182 0.685 0.756 0.969 
Yes 106 0.721 0.0186 0.685 0.758 
 
Table 15. ANOVA analysis of APHs for samples created from donor A using the 10-cell and 
100-cell extraction protocols with and without pre-PCR sampling. 
AT Used? Pre-PCR 
Sampling? 
Number 
of Loci 
Mean  APH (rfu) Standard 
Error 
Lower 
95% 
Upper 
95% 
p-value 
30 rfu No 109 56.8 2.05 52.8 60.9 0.0028 
Yes 123 65.3 1.93 61.5 69.1 
10 rfu No 150 47.4 2.01 43.4 51.3 <0.0001 
Yes 144 59.5 2.06 55.4 63.5 
 
3.4 Comparison of Molecular Crowding 
The effect of molecular crowding was examined to determine whether cRNA can 
improve amplification signal and PH imbalance in LTDNA samples. DNA was extracted 
from donor C using the cell transfer/reduced volume protocol where 10 cells were 
collected and extracted. Half of the samples were then directly amplified while 1 µL of 1 
µg/µL of cRNA was added to the remaining samples prior to amplification (Figure 12). 
No statistical differences in mean PHR or APH were observed between these two 
conditions (Figure 13; Table 16 and 17). In the AT of 30 rfu analysis, one ADO was 
observed in the samples with cRNA but its exclusion or inclusion did not statistically 
change the results. Therefore the presence of cRNA neither assisted nor inhibited 
amplification based on the data in this experiment. 
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Figure 12. Flowchart of the addition of cRNA. The cell transfer and forensicGEM® reduced 
volume protocols were used to create 10-cells extracts (A) without the addition of cRNA and (B) 
with the addition of cRNA prior to amplification. 
 
 
 
Figure 13. Mean comparison of PHRs and APHs for samples created from donor C using 
the 10-cell extraction with and without cRNA. Buccal epithelial cells from donor C were 
extracted to the target mass of 0.0625 ng. Samples were amplified with and without the addition 
of 1 µg cRNA. PHR (A) and APH (B) were analyzed with ANOVA with an AT of 30 rfu. 
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Table 16. ANOVA analysis of PHRs for samples created from donor C using the 10-cell 
extraction with and without cRNA. 
ADOs 
included? 
Contains 
cRNA? 
Number 
of Loci 
Mean 
PHR 
Standard 
Error 
Lower 
95% 
Upper 
95% 
p-value 
No No 110 0.808 0.0131 0.783 0.834 0.713 
Yes 109 0.815 0.0131 0.789 0.841 
Yes No 110 0.808 0.0133 0.782 0.835 0.863 
Yes 110 0.812 0.0133 0.786 0.838 
 
Table 17. ANOVA analysis of APHs for samples created from donor C using the 10-cell 
extraction with and without cRNA. 
ADOs 
included? 
Contains 
cRNA? 
Number 
of Loci 
Mean APH (rfu) Standard 
Error 
Lower 
95% 
Upper 
95% 
p-value 
No No 150 184 5.14 174 194 0.500 
Yes 149 189 5.16 179 199 
Yes No 150 184 5.19 174 194 0.602 
Yes 150 188 5.19 178 198 
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4. CONCLUSIONS 
4.1 Amplification of LTDNA 
LTDNA profiles are difficult to interpret due to increased stochastic effects. A 
range of DNA mass was examined from 0.0375 ng, which is equivalent to the genomic 
DNA mass in 6 cells, to 0.125 ng, which is equivalent to the genomic DNA mass in 20 
cells. Regardless of extraction method used, as target mass decreased, PH imbalance 
increased, which agrees with what has been previously observed in the literature12,13,29,31. 
However at all masses examined, mean PHR was greater than 0.6 except in samples 
diluted from the full volume extract to the target mass of 0.0375 ng. When ADOs are 
included in these 0.0375 ng diluted samples, the mean PHR is 0.587, but when ADOs are 
excluded, the mean PHR is 0.731; however with ADOs excluded there would be a great 
loss of data since 44 of the possible 110 loci would be removed. The cell transfer/reduced 
volume extracts at this target mass, on the other hand, had mean PHR of 0.760 when 
ADOs are included, and 0.768 when ADOs are excluded. Typically PHRs of at least 0.6 
are expected for single-source samples18. Therefore the analysis of LTDNA profiles 
obtained from the amplification of 0.0625 ng of DNA can provide valuable information, 
and, when a cell collection, single-tube extraction, and direct amplification method are 
utilized, full ID+ profiles can reliably be obtained from as few as 6 cells. 
 
4.2 Comparison of Pre-PCR Sampling Error and PCR Chemistry Error 
One goal of this research was to replicate results obtained by Kaeser in 
differentiating the effects of pre-PCR sampling and PCR chemistry on PH imbalance35. 
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In order to do so, protocols similar to the ones developed by Kaeser were used. Samples 
were created where specific numbers of cells were collected into a tube, followed by a 
single-tube extraction method using forensicGEM® and direct amplification using ID+. 
These cell transfer samples would only show the effects of PCR chemistry since pipetting 
and tube transferal steps were removed. They were compared to samples amplified from 
aliquots of comparable mass taken from dilutions of the forensicGEM® full volume 
extract. These diluted samples would show the effect of both PCR chemistry and pre-
PCR sampling. 
In general we were able to replicate Kaeser’s results. She examined samples at the 
target mass of 0.0625 ng and 0.125 ng while we also looked at 0.0375 ng. Kaeser found 
that, although mean PHRs were closer to one at both mass for samples without pre-PCR 
sampling, only the 0.0625 ng sample was significant35. Our results, on the other hand, 
were significant at both of those masses as well as at 0.0375 ng when ADOs are 
excluded. However we saw a reversal in the direction for APH. Kaeser saw a significant 
difference where her diluted samples had a higher APH compared to her cell transfer 
samples at 0.0625 ng and 0.125 ng while our cell transfer samples saw a significantly 
higher APH than the diluted samples at the three masses we examined. 
In order to observe the effects of pre-PCR sampling and PCR chemistry errors on 
PHR it is important to have accurate amount of DNA. However it is difficult to 
accurately quantify DNA especially in dilute samples15,30. Using APH as an indicator for 
DNA mass, the difference in PHs between the cell transfer and diluted samples suggests 
our DNA quantity may not be as expected. Although quantification of our 0.125 ng 
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diluted samples were higher than the target mass, APH suggest it was lower than the 
target mass. 
Due to the difficulties in accurately diluting and quantifying samples, we used the 
cell transfer method to create either 10-cell or 100-cell extracts, which both had the target 
mass of 0.0625 ng in 10 µL. The 10-cell extracts were directly amplified while the 100-
cell extract had 10 µL aliquots taken for amplification. The 10-cell directly amplified 
samples would only exhibit the effects of PCR chemistry while the 100-cell aliquots 
would exhibit both PCR chemistry and pre-PCR sampling. We performed this experiment 
three times. In two of the three experiments mean PHR of the 10-cell extracts were 
significantly higher than those with pre-PCR sampling errors, however APH of the first 
experiment was significantly different between the 10-cell and 100-cell samples while 
they were not significantly different in the second experiment. The difference in mean 
PHR in the first experiment may be due to pre-PCR sampling and difference in DNA 
mass, while the difference in mean PHR in the second experiment is likely due to 
sampling. 
These results suggest that by minimizing pre-PCR sampling, one can improve PH 
balance in LTDNA samples. However pre-PCR sampling is not the sole source of 
stochastic effects since ADOs and PH imbalance are still observed in the cell transfer 
samples with only PCR chemistry. While removing pre-PCR sampling steps improved 
PH balance, the mean PHR was not 1, which one would expect if both sister alleles at a 
heterozygous locus were amplified evenly. Instead we observed mean PHRs of 
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approximately 0.8 for the 0.0625 ng samples, which is equivalent to the genomic DNA in 
10 cells, in the two experiments. 
Timken et al. examined samples with the genomic DNA mass from 
approximately 8 cells32. They simulated data comparing PHRs of samples with only PCR 
chemistry error, samples with only pre-PCR sampling error, and samples with both pre-
PCR sampling and PCR chemistry errors. The mean PHRs of our cell transfer samples 
with pre-PCR sampling and PCR chemistry falls close to their median PHR of 0.7. 
However our mean PHRs for cell transfer samples with only PCR chemistry falls below 
their estimates. While we had a mean PHR of approximately 0.8 for our two experiments, 
Timken et al. had a median PHR of approximately 0.9 for their 8-cell simulations, with a 
25% percentile of roughly 0.85. Since these simulations are for 8-cell samples, we can 
assume the simulated PHRs for 10-cell samples would be greater than their 8-cell sample, 
yet we observed lower PHRs. Their simulations had assumed a PCR replication 
efficiency of 85%, however we believe this is an overestimation at this level of mass. 
The result of the third experiment comparing cell transfer samples with and 
without pre-PCR sampling was different from our previous two. Mean PHR was not 
significantly different but APH was where the APH of the samples with pre-PCR 
sampling was greater than those without sampling. It is possible the PHR result was 
minimized due to the difference in PH and therefore the difference in DNA mass. 
Additionally there was a large number of ADOs. Although performed months apart, the 
same ID+  kit was used for the second and third experiment. A different DNA donor was 
used. These results further illustrate the importance of accurate DNA amounts when 
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comparing PHRs in LTDNA. It is also important to further replicate this experimental 
design in multiple DNA donors as well as using different amplification kits. 
 
4.3 Molecular Crowding 
One way to improve LTDNA profiles is to improve amplification. Ballantyne et 
al. were able to improve allele recovery by using molecular crowding agents, such as a 
glycol and animal DNA, during WGA26. Similarly we compared 10-cell extracts with and 
without cRNA added prior to amplification. We flooded the 0.0625 ng sample with 1 µg 
of cRNA and our results showed no differences in either mean PHR or APH. The 
addition of cRNA neither improved nor hindered amplification. It is possible that 
molecular crowding may assist in WGA but not in conventional PCR. 
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